Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 910,800 shares, an increase of 102.2% from the October 15th total of 450,400 shares. Based on an average trading volume of 2,420,000 shares, the short-interest ratio is currently 0.4 days. Approximately 10.4% of the company’s shares are short sold.
Aditxt Price Performance
Shares of ADTX stock opened at $0.35 on Friday. The stock has a fifty day moving average of $5.97 and a 200 day moving average of $42.69. Aditxt has a 52 week low of $0.32 and a 52 week high of $380.00.
Aditxt (NASDAQ:ADTX – Get Free Report) last issued its quarterly earnings data on Monday, August 19th. The company reported ($167.60) EPS for the quarter. The business had revenue of $0.04 million for the quarter.
Insiders Place Their Bets
About Aditxt
Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.
See Also
- Five stocks we like better than Aditxt
- Investing in Construction Stocks
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- The Basics of Support and Resistance
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Stock Dividend Cuts Happen Are You Ready?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.